|
Peptides
Avian Influenza Hemagglutinin Peptide
Background
Avian Influenza Hemagglutinin (N-Terminus) Peptide
Location
15 amino acids near the amino terminus of Avian Influenza A (H5N1) hemagglutinin.
Application
The peptide is used for blocking the activity of the avian influenza hemagglutinin antibody (Cat. No. 3427). It usually blocks the antibody activity completely in ELISA assays by incubating the peptide with equal volume of antibody for 30 min at 37˚C.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
Avian influenza hemagglutinin peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
V
Short Description
(NT) Avian influenza hemagglutinin peptide
This product belongs to the following categories:
Related Products
References- Sancho E, Vila MR, Sanchez-Pulido L, et al. Role of UEV-1, an inactive variant of the E2 ubiquitin-conjugating enzymes, in in vitro differentiation and cell cycle behavior of HT-29-M6 intestinal mucosecretory cells. Mol. Cell Biol. 1998; 18:576-89.
- Akira S and Takeda K. Toll-like receptor Signalling. Nat. Rev. Immunol. 2004; 4:499-511.
- Vogel SN, Fitzgerald KA, and Fenton MJ. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 2003; 3:466-77.
- Deng L, Wang C, Spencer E, et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 2000; 103:351-61.
Datasheet 0801-W
|
|
